These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38668366)
1. Anaplerotic Therapy Using Triheptanoin in Two Brothers Suffering from Aconitase 2 Deficiency. Penkl M; Mayr JA; Feichtinger RG; Reilmann R; Debus O; Fobker M; Penkl A; Reunert J; Rust S; Marquardt T Metabolites; 2024 Apr; 14(4):. PubMed ID: 38668366 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy. Metodiev MD; Gerber S; Hubert L; Delahodde A; Chretien D; Gérard X; Amati-Bonneau P; Giacomotto MC; Boddaert N; Kaminska A; Desguerre I; Amiel J; Rio M; Kaplan J; Munnich A; Rötig A; Rozet JM; Besmond C J Med Genet; 2014 Dec; 51(12):834-8. PubMed ID: 25351951 [TBL] [Abstract][Full Text] [Related]
3. Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: Delineation of an emerging neurometabolic syndrome. Sharkia R; Wierenga KJ; Kessel A; Azem A; Bertini E; Carrozzo R; Torraco A; Goffrini P; Ceccatelli Berti C; McCormick ME; Plecko B; Klein A; Abela L; Hengel H; Schöls L; Shalev S; Khayat M; Mahajnah M; Spiegel R J Inherit Metab Dis; 2019 Mar; 42(2):264-275. PubMed ID: 30689204 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel compound heterozygous mutations in ACO2 in a patient with progressive cerebral and cerebellar atrophy. Fukada M; Yamada K; Eda S; Inoue K; Ohba C; Matsumoto N; Saitsu H; Nakayama A Mol Genet Genomic Med; 2019 Jul; 7(7):e00698. PubMed ID: 31106992 [TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency due to a novel ACO2 deletion causes mitochondrial dysfunction in fibroblasts from a patient with dominant optic nerve atrophy. Neumann MA; Grossmann D; Schimpf-Linzenbold S; Dayan D; Stingl K; Ben-Menachem R; Pines O; Massart F; Delcambre S; Ghelfi J; Bohler J; Strom T; Kessel A; Azem A; Schöls L; Grünewald A; Wissinger B; Krüger R Sci Rep; 2020 Oct; 10(1):16736. PubMed ID: 33028849 [TBL] [Abstract][Full Text] [Related]
6. Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2. Spiegel R; Pines O; Ta-Shma A; Burak E; Shaag A; Halvardson J; Edvardson S; Mahajna M; Zenvirt S; Saada A; Shalev S; Feuk L; Elpeleg O Am J Hum Genet; 2012 Mar; 90(3):518-23. PubMed ID: 22405087 [TBL] [Abstract][Full Text] [Related]
7. Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency. Sadat R; Barca E; Masand R; Donti TR; Naini A; De Vivo DC; DiMauro S; Hanchard NA; Graham BH Mol Genet Metab; 2016 May; 118(1):28-34. PubMed ID: 26992325 [TBL] [Abstract][Full Text] [Related]
8. Novel compound heterozygous ACO2 mutations in an infant with progressive encephalopathy: A newly identified neurometabolic syndrome. Park JS; Kim MJ; Kim SY; Lim BC; Kim KJ; Seong MW; Lee JS; Chae JH Brain Dev; 2020 Oct; 42(9):680-685. PubMed ID: 32713659 [TBL] [Abstract][Full Text] [Related]
10. Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. Park MJ; Aja S; Li Q; Degano AL; Penati J; Zhuo J; Roe CR; Ronnett GV PLoS One; 2014; 9(10):e109527. PubMed ID: 25299635 [TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization on muscle tissue of a novel biallelic Ricci FS; Stanga S; Mezzanotte M; Marinaccio C; D'Alessandro R; Somà A; Sottemano S; Conio A; Morana G; Spada M; Boido M; Mongini TE JIMD Rep; 2024 Jan; 65(1):3-9. PubMed ID: 38186851 [TBL] [Abstract][Full Text] [Related]
13. Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant. Srivastava S; Gubbels CS; Dies K; Fulton A; Yu T; Sahin M J Child Neurol; 2017 Aug; 32(9):840-845. PubMed ID: 28545339 [TBL] [Abstract][Full Text] [Related]
14. Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2. Blackburn PR; Schultz MJ; Lahner CA; Li D; Bhoj E; Fisher LJ; Renaud DL; Kenney A; Ibrahim N; Hashem M; Zain Seidahmed M; Hasadsri L; Schrier Vergano SA; Alkuraya FS; Lanpher BC Ann Clin Transl Neurol; 2020 Jun; 7(6):1013-1028. PubMed ID: 32519519 [TBL] [Abstract][Full Text] [Related]
15. Case Report: Infantile Cerebellar-Retinal Degeneration With Compound Heterozygous Variants in Ha DJ; Park J; Seo GH; Lee K; Kwon YS; Lee JE; Kim SJ Front Genet; 2022; 13():729980. PubMed ID: 35368710 [TBL] [Abstract][Full Text] [Related]
16. Recessive ACO2 variants as a cause of isolated ophthalmologic phenotypes. Gibson S; Azamian MS; Lalani SR; Yen KG; Sutton VR; Scott DA Am J Med Genet A; 2020 Aug; 182(8):1960-1966. PubMed ID: 32449285 [TBL] [Abstract][Full Text] [Related]
18. Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling. You X; Tian J; Zhang H; Guo Y; Yang J; Zhu C; Song M; Wang P; Liu Z; Cancilla J; Lu W; Glorieux C; Wen S; Du H; Huang P; Hu Y Mol Metab; 2021 Jun; 48():101203. PubMed ID: 33676027 [TBL] [Abstract][Full Text] [Related]